Cargando…

Impact of the Patient Protection and Affordable Care Act on 1-year survival in glioblastoma patients

BACKGROUND: Glioblastoma (GBM) treatment requires access to complex medical services, and the Patient Protection and Affordable Care Act (ACA) sought to expand access to health care, including complex oncologic care. Whether the implementation of the ACA was subsequently associated with changes in 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moghavem, Nuriel, Oh, Debora L, Santiago-Rodríguez, Eduardo J, Tate, William J, Gomez, Scarlett Lin, Thomas, Reena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388609/ https://www.ncbi.nlm.nih.gov/pubmed/32743549 http://dx.doi.org/10.1093/noajnl/vdaa080

Ejemplares similares

Proteins inform survival-based differences in patients with glioblastoma
por: Stetson, L C, et al.
Publicado: (2020)

MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
por: Hübner, Max, et al.
Publicado: (2020)

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
por: Gittleman, Haley, et al.
Publicado: (2019)

Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
por: Nuechterlein, Nicholas, et al.
Publicado: (2021)

Functional connectivity within glioblastoma impacts overall survival
por: Daniel, Andy G S, et al.
Publicado: (2020)

5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma—a comparative cohort study of 343 patients
por: Baig Mirza, Asfand, et al.
Publicado: (2021)

Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients
por: Reyes-González, Jesús, et al.
Publicado: (2022)

Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma
por: Nesterova, Darya S, et al.
Publicado: (2020)

Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma
por: Taylor, Jessica T, et al.
Publicado: (2020)

Structural gray matter alterations in glioblastoma and high-grade glioma—A potential biomarker of survival
por: Lamichhane, Bidhan, et al.
Publicado: (2023)

Multiomics profiling of paired primary and recurrent glioblastoma patient tissues
por: Dekker, Lennard J M, et al.
Publicado: (2020)

Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival
por: Kersch, Cymon N, et al.
Publicado: (2020)

Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019)

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models
por: Conage-Pough, Jason E, et al.
Publicado: (2023)

Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo
por: Szabo, Emese, et al.
Publicado: (2016)

Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study
por: Malay, Sindhoosha, et al.
Publicado: (2020)

Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts
por: Almstedt, Elin, et al.
Publicado: (2021)

Single-cell image analysis reveals a protective role for microglia in glioblastoma
por: Woolf, Zoe, et al.
Publicado: (2021)

On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022)

Spectral flow cytometry identifies distinct nonneoplastic plasma extracellular vesicle phenotype in glioblastoma patients
por: Aibaidula, Abudumijiti (Zack), et al.
Publicado: (2023)

Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020)

A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses
por: Gomez-Roman, Natividad, et al.
Publicado: (2017)

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022)

Preoperative imaging of glioblastoma patients using hyperpolarized (13)C pyruvate: Potential role in clinical decision making
por: Chen, Jun, et al.
Publicado: (2021)

GammaTile® brachytherapy in the treatment of recurrent glioblastomas
por: Gessler, Dominic J, et al.
Publicado: (2021)

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2021)

Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies
por: Singleton, Kyle W, et al.
Publicado: (2020)

The invasive proteome of glioblastoma revealed by laser-capture microdissection
por: Daubon, Thomas, et al.
Publicado: (2019)

Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect
por: Gibson, David, et al.
Publicado: (2023)

Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients
por: Yekula, Anudeep, et al.
Publicado: (2023)

Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022)

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
por: Porath, Kendra A, et al.
Publicado: (2022)

Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010)

CRN2 enhances the invasiveness of glioblastoma cells
por: Ziemann, Anja, et al.
Publicado: (2013)

Expression of pluripotency-related genes in human glioblastoma
por: Rios, Álvaro Fabrício Lopes, et al.
Publicado: (2021)

Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
por: Abou-El-Ardat, Khalil, et al.
Publicado: (2017)

The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
por: Hoogstrate, Youri, et al.
Publicado: (2021)

Glioblastoma cytotoxicity conferred through dual disruption of endolysosomal homeostasis by Vacquinol-1
por: Kwak, Dongoh, et al.
Publicado: (2021)

Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy
por: Nakagawa, Tomoyoshi, et al.
Publicado: (2022)

Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma
por: Lloyd, Rhiannon E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e9p2puavlujra2fpeiilap8nsg